117 HRES 1274 RH: Of inquiry directing the President to provide certain documents in the President’s possession to the House of Representatives relating to communications by or among any of the Department of Health and Human Services, the Office of National Drug Control Policy, the White House, the Drug Enforcement Administration, and the Department of Justice related to the executive branch’s recommendations for a long-term, consensus approach to reduce the supply and availability of illicitly manufactured fentanyl-related substances in the United States. U.S. House of Representatives 2022-09-29 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

IVHouse Calendar No. 133117th CONGRESS2d SessionH. RES. 1274[Report No. 117–527]IN THE HOUSE OF REPRESENTATIVESJuly 26, 2022Mr. Latta (for himself and Mr. Dunn) submitted the following resolution; which was referred to the Committee on Energy and CommerceSeptember 29, 2022Reported without recommendation from the Committee on Energy and Commerce, referred to the House Calendar, and ordered to be printedRESOLUTIONOf inquiry directing the President to provide certain documents in the President’s possession to the House of Representatives relating to communications by or among any of the Department of Health and Human Services, the Office of National Drug Control Policy, the White House, the Drug Enforcement Administration, and the Department of Justice related to the executive branch’s recommendations for a long-term, consensus approach to reduce the supply and availability of illicitly manufactured fentanyl-related substances in the United States.

That, not later than 14 days after the adoption of this resolution, the President is directed to furnish to the House of Representatives copies of any document or communication in the President’s possession that refers or relates to communications by or among any of the Department of Health and Human Services, the Office of National Drug Control Policy, the White House, the Drug Enforcement Administration, and the Department of Justice related to the executive branch’s recommendations for a long-term, consensus approach to reduce the supply and availability of illicitly manufactured fentanyl-related substances in the United States.

September 29, 2022Reported without recommendation from the Committee on Energy and Commerce, referred to the House Calendar, and ordered to be printed